Lumexa Imaging LMRI
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 1st percentile, 5-year average -30.5x
Above its usual level · 69th percentile, 5-year average 3.7x
#3294 of 5329 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 80th percentile, 5-year average 1.1x
#2029 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.24 | – | 3.66 | 69% (pricier than usual) | #3294 of 5329 (1 = cheapest) |
| PE | -83.67 | 21.21 | -30.54 | 1% (cheaper than usual) | – |
| PS | 1.35 | 1.28 | 1.08 | 80% (pricier than usual) | #2029 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on LMRI.
Sign in to join the discussion.